中华消化内镜杂志
中華消化內鏡雜誌
중화소화내경잡지
Chinese Journal of Digestive Endoscopy
2015年
8期
521-524
,共4页
刘杰%周玮%张玲%林寒%赵九龙%李桂香%施新岗%邹多武%赵铁军
劉傑%週瑋%張玲%林寒%趙九龍%李桂香%施新崗%鄒多武%趙鐵軍
류걸%주위%장령%림한%조구룡%리계향%시신강%추다무%조철군
安全性%临床疗效%贲门失驰缓症%经口内镜肌切开术
安全性%臨床療效%賁門失馳緩癥%經口內鏡肌切開術
안전성%림상료효%분문실치완증%경구내경기절개술
Safety%Clinical outcome%Achalasia%Peroral endoscopic myotomy
目的 探讨既往有内镜或外科Heller肌切开术治疗史的贲门失弛缓症(AC)患者行经口内镜下肌切开术(POEM)治疗的有效性和安全性.方法 回顾性分析2011年10月至2014年4月间行POEM治疗的164例AC患者的临床资料,根据POEM术前是否进行过内镜或外科Heller肌切开术,分为复治组和初治组,比较围手术期资料及术前、术后患者Eckardt评分变化情况.结果 复治组58例,初治组106例.2组患者的POEM成功率分别为94.8% (55/58)和98.1% (104/106),差异无统计学意义(P=0.09).所有患者中位随访时间17个月(6~30个月),术后症状明显改善,且术后1个月、12个月、24个月Eckardt评分(≤3分)较术前(4~11分)明显降低.随访期间复治组与初治组各有1例复发,症状缓解率98.7% (157/159).复治组平均操作时间、住院天数及使用止血夹数量均多于初治组,分别是(70.8±20.7)min比(68.3 ±27.1)min、(7.7±1.9)d比(7.5±2.6)d、(13.0±5.7)个比(12.7±5.6)个,但2组比较差异均无统计学意义(P>0.05).复治组和初治组并发症发生率分别是9.1% (5/55)、8.7% (9/104),差异也无统计学意义(P=0.93).结论 既往有内镜或外科治疗史的AC患者,POEM治疗仍然安全有效.
目的 探討既往有內鏡或外科Heller肌切開術治療史的賁門失弛緩癥(AC)患者行經口內鏡下肌切開術(POEM)治療的有效性和安全性.方法 迴顧性分析2011年10月至2014年4月間行POEM治療的164例AC患者的臨床資料,根據POEM術前是否進行過內鏡或外科Heller肌切開術,分為複治組和初治組,比較圍手術期資料及術前、術後患者Eckardt評分變化情況.結果 複治組58例,初治組106例.2組患者的POEM成功率分彆為94.8% (55/58)和98.1% (104/106),差異無統計學意義(P=0.09).所有患者中位隨訪時間17箇月(6~30箇月),術後癥狀明顯改善,且術後1箇月、12箇月、24箇月Eckardt評分(≤3分)較術前(4~11分)明顯降低.隨訪期間複治組與初治組各有1例複髮,癥狀緩解率98.7% (157/159).複治組平均操作時間、住院天數及使用止血夾數量均多于初治組,分彆是(70.8±20.7)min比(68.3 ±27.1)min、(7.7±1.9)d比(7.5±2.6)d、(13.0±5.7)箇比(12.7±5.6)箇,但2組比較差異均無統計學意義(P>0.05).複治組和初治組併髮癥髮生率分彆是9.1% (5/55)、8.7% (9/104),差異也無統計學意義(P=0.93).結論 既往有內鏡或外科治療史的AC患者,POEM治療仍然安全有效.
목적 탐토기왕유내경혹외과Heller기절개술치료사적분문실이완증(AC)환자행경구내경하기절개술(POEM)치료적유효성화안전성.방법 회고성분석2011년10월지2014년4월간행POEM치료적164례AC환자적림상자료,근거POEM술전시부진행과내경혹외과Heller기절개술,분위복치조화초치조,비교위수술기자료급술전、술후환자Eckardt평분변화정황.결과 복치조58례,초치조106례.2조환자적POEM성공솔분별위94.8% (55/58)화98.1% (104/106),차이무통계학의의(P=0.09).소유환자중위수방시간17개월(6~30개월),술후증상명현개선,차술후1개월、12개월、24개월Eckardt평분(≤3분)교술전(4~11분)명현강저.수방기간복치조여초치조각유1례복발,증상완해솔98.7% (157/159).복치조평균조작시간、주원천수급사용지혈협수량균다우초치조,분별시(70.8±20.7)min비(68.3 ±27.1)min、(7.7±1.9)d비(7.5±2.6)d、(13.0±5.7)개비(12.7±5.6)개,단2조비교차이균무통계학의의(P>0.05).복치조화초치조병발증발생솔분별시9.1% (5/55)、8.7% (9/104),차이야무통계학의의(P=0.93).결론 기왕유내경혹외과치료사적AC환자,POEM치료잉연안전유효.
Objective To explore the clinical efficacy and safety of peroral endoscopic myotomy (POEM) for achalasia(AC) with or without prior endoscopic or surgical procedures.Methods The clinical data of 164 patients with severe achalasia who were admitted to our hospital from October 2011 to April 2014 were retrospectively analyzed.They were assigned to the retreatment group and the initial treatment group.The perioperative clinical data and Eckwardt scores before and after the operation were compared.Results A total of 164 patients were enrolled, 58 of whom already received prior endoscopic or surgical procedures for therapy were in the retreatment group, and the other 106 patients of whom hadn't any treatment for achalasia were in the initial treatment group.The success rates of POEM in two groups were 94.8% (55/58) and 98.1% (104/106) , with no significant difference (P > 0.05).Median follow-up time was 17 months (ranging 6-30) , and the symptoms of patients relieved after treatment.The Eckardt scores at 1,12 and 24 months after the operation were ≤ 3, which were lower than that before operation (4-11).During follow-up time, one recurrence happened in each group, and symptom relief rate was 98.7% (157/159).The operation time , hospital stay and number of Hemostatic clips in the retreatment group was more than that of initial group , (70.8 ±20.7)min VS(68.3 ±27.1) min,(7.7 ± 1.9)day VS (7.5 ±2.6)day, (13.0 ±5.7) piece VS (12.7 ± 5.6) piece, respectively, with no significant difference (P > 0.05).The incidence of complications of the retreatment group and initial group were 9.1% (5/55) and 8.7% (9/104), with no significant difference (P =0.93).Conclusion POEM is an effective and safe method for the AC who have previous endoscopic or surgical treatment.